Sponsor:
Mayo Clinic
Code:
NCT05109208
Conditions
Prostate Adenocarcinoma
Eligibility Criteria
Sex: Male
Age: 40+
Healthy Volunteers: Not accepted
Interventions
Ulrasound Vibroelastography (UVE)
Brief summary:
Conditions
Prostate Adenocarcinoma
Study ID
NCT05109208
Start date
Oct 2, 2023
Status verified date
Jun, 2026
Completion date
Oct 31, 2028
Anticipated
Primary completion date
Oct 31, 2028
Anticipated
Eligibility Criteria
Sex: Male
Age: 40+
Healthy Volunteers: Not accepted
Enrollment
10 participants
Anticipated
Intervention Model
Single group
Primary purpose
Health Services Research
Arms
experimental: Ultrasound viscoelastography (UVE) in radical proctectomy recovery
Interventions
Ulrasound Vibroelastography (UVE)
Primary outcome measure
Locations
Mayo Clinic in Rochester
Recruiting
Rochester, Minnesota, United States, 55905
Contacts
Principal Investigator:
Matt J. Ziegelmann, M.D.
Sponsor
Mayo Clinic
Last update posted
Jun 9, 2026
Last verified
Jun, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2026-06-09.